SIGi001-A-4

iPSC0028 MAPT P301L D4

General#

Cell Line

hPSCreg Name SIGi001-A-4
Alternative name(s)
iPSC0028 MAPT P301L D4
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 23rd October 2017
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Sigma-Aldrich (SIG)
Owner Janssen Pharmaceutica (JP)
Distributors

External Databases

BioSamples SAMEA4448632
Cellosaurus CVCL_EF85
ECACC 66540332
EBiSC SIGi001-A-4

General Information

Is the cell line available in principle? Available with restrictions: Available for clinical and commercial research
Subclone of

Donor Information#

General Donor Information

Sex female
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA4447434

Ethics#

We are currently revising this section.

hIPSC Derivation#

General

The source cell information can be found in the parental cell line SIGi001-A.

Reprogramming method

Vector type Integrating
Vector Virus (Retrovirus)
Genes
Is the used vector excisable?
Unkown
Absence of reprogramming vector(s)?
Unkown
Reprogramming vectors silenced?

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions#

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium mTeSR™ 1

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SSEA-4
Yes
TRA 1-60
Yes
SSEA-1
No
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
GATA6
Yes
TBX5
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
AFP
Yes
SERPINA
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
PAX6
Yes
NeuroD
Yes

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
No autosomal or sex chromosome aneuploidies detected
Karyotyping method: BoBs

Other Genotyping (Cell Line)

Genetic Modification#

Disease/phenotype related modifications
Frontotemporal dementia
Synonyms
  • FTD
Genetic modifications
MAPT (target)
Isogenic modification
17q21.31
NM_016834.4 : c.728C>T
NP_005901.2:p.Pro301Leu
Heterozygous
Mutated